My comments were intended to refer specifically to the use of what I would call “non-science-based issues”, such as market assessment in our regulatory framework. My intent is certainly not to dwell on the issue of emotion, and I apologize if that's taken incorrectly.
I think our emphasis must be on the scientific basis. Indeed, with regard to your comment about Argentina, Argentina is a country that produces genetically modified soybeans in fairly large amounts. Just recently, I was given to understand through documentation that Argentina is indeed developing guidelines very similar to those of North America around recognizing the need to protect the technology and to use that technology to support its producers in a fair and equal way, since the producers in Brazil are now using this technology.
I point again to the area of canola development. I think there was a very important and good dialogue about how new technology would be used in the canola industry, and I think it formed an example of how we can use the science-based regulatory framework and still make progress in dealing with trade and marketing issues.